Literature DB >> 8773458

Involvement of dopamine D3 receptors in the area postrema in R(+)-7-OH-DPAT-induced emesis in the ferret.

T Yoshikawa1, N Yoshida, K Hosoki.   

Abstract

We investigated the possible involvement of dopamine D3 receptors in R(+)-7-hydroxy-2-(N,N-di-n-propylamino)tetraline (R(+)-7-OH-DPAT)-induced emesis in the ferret. The R(+)enantiomer of 7-OH-DPAT (0.03-1 mg/kg, s.c.) caused emesis in a dose-dependent manner, whereas the S(-)enantiomer, even at 1 mg/kg s.c. failed to induce emesis. Quinpirole (0.1-1.0 mg/kg) and apomorphine (0.3 mg/kg, s.c. only) also elicited an emetic response. S(-)-Eticlopride, which has a high affinity for the dopamine D3 receptor, antagonized R(+)-7-OH-DPAT (0.3 mg/kg, s.c.)-induced emesis (ID50 1.4 micrograms/kg, s.c.). R(+)-7-OH-DPAT (0.1-1.0 microgram) administered into the 4th cerebral ventricle dose dependently induced emesis within 1 min of dosing in ferrets. Intracerebroventricularly administered S(-)-eticlopride (0.01-1 microgram) also inhibited the emesis induced by s.c. administration of R(+)-7-OH-DPAT. The emetic effect of R(+)-7-OH-DPAT was unaffected by abdominal vagotomy but was markedly reduced by ablation of the area postrema. These results suggest that dopamine D3 receptors in the area postrema play an important role in R(+)-7-OH-DPAT-induced emesis in the ferret.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8773458     DOI: 10.1016/0014-2999(96)00061-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist.

Authors:  T Yoshikawa; N Yoshida; M Oka
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Comparison of the D₁ dopamine full agonists, dihydrexidine and doxanthrine, in the 6-OHDA rat model of Parkinson's disease.

Authors:  John D McCorvy; Val J Watts; David E Nichols
Journal:  Psychopharmacology (Berl)       Date:  2012-01-06       Impact factor: 4.530

3.  Male and female rats exhibit comparable gaping behavior but activate brain regions differently during expression of conditioned nausea.

Authors:  Alyssa Bernanke; Samantha Sette; Nathaniel Hernandez; Sara Zimmerman; Justine Murphy; Reynold Francis; Zackery Reavis; Cynthia Kuhn
Journal:  Behav Pharmacol       Date:  2022-05-10       Impact factor: 2.277

4.  Receptor-selective agonists induce emesis and Fos expression in the brain and enteric nervous system of the least shrew (Cryptotis parva).

Authors:  Andrew P Ray; Seetha Chebolu; Nissar A Darmani
Journal:  Pharmacol Biochem Behav       Date:  2009-08-21       Impact factor: 3.533

5.  The D2/D3 agonist PD128907 (R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol) inhibits stimulated pyloric relaxation and spontaneous gastric emptying.

Authors:  Purna Kashyap; Maria-Adelaide Micci; Sarina Pasricha; Pankaj Jay Pasricha
Journal:  Dig Dis Sci       Date:  2008-07-04       Impact factor: 3.199

Review 6.  Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT₃ receptor antagonists.

Authors:  N Percie du Sert; J A Rudd; C C Apfel; P L R Andrews
Journal:  Cancer Chemother Pharmacol       Date:  2010-05-28       Impact factor: 3.333

7.  Signal transduction pathways involved in dopamine D2 receptor-evoked emesis in the least shrew (Cryptotis parva).

Authors:  Louiza Belkacemi; Weixia Zhong; Nissar A Darmani
Journal:  Auton Neurosci       Date:  2021-04-10       Impact factor: 2.355

8.  Anti-emetic mechanisms of Zingiber officinale against cisplatin induced emesis in the pigeon; behavioral and neurochemical correlates.

Authors:  Ihsan Ullah; Fazal Subhan; Muhammad Ayaz; Rehmat Shah; Gowhar Ali; Ikram Ul Haq; Sami Ullah
Journal:  BMC Complement Altern Med       Date:  2015-02-26       Impact factor: 3.659

Review 9.  The Benefits of Olanzapine in Palliating Symptoms.

Authors:  Mellar P Davis; Gareth J Sanger
Journal:  Curr Treat Options Oncol       Date:  2020-11-26

10.  Suppression of Cisplatin-Induced Vomiting by Cannabis sativa in Pigeons: Neurochemical Evidences.

Authors:  Ihsan Ullah; Fazal Subhan; Javaid Alam; Muhammad Shahid; Muhammad Ayaz
Journal:  Front Pharmacol       Date:  2018-03-16       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.